GW PHARMACEUTICALS PLC Diluted Shares Outstanding (Weighted Average)
GW PHARMACEUTICALS PLC reported Diluted Shares Outstanding (Weighted Average) of 378.57 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2021-05-03
- GW PHARMACEUTICALS PLC weighted average number of shares outstanding, diluted for the quarter ending 2021-03-31 was 378.57M shares, a 1.27% increase year-over-year.
- GW PHARMACEUTICALS PLC weighted average number of shares outstanding, diluted for the quarter ending 2020-12-31 was 376.68K shares, a 1.14% increase year-over-year.
- GW PHARMACEUTICALS PLC weighted average number of shares outstanding, diluted for the quarter ending 2020-09-30 was 376.28K shares, a 1.08% increase year-over-year.
- GW PHARMACEUTICALS PLC weighted average number of shares outstanding, diluted for the quarter ending 2020-06-30 was 375.52K shares, a 0.51% decline year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | 378.57M shares 10-Q · filed 2021-05-03 | 189.47M shares derived: average of 2 quarters · filed 2021-05-03 | 126.44M shares derived: average of 3 quarters · filed 2021-05-03 | 94.92M shares derived: average of 4 quarters · filed 2021-05-03 | |
| 2020-12-31 | 376.68K shares 10-K · filed 2021-02-26 | 376.48K shares derived: average of 2 quarters · filed 2021-02-26 | 376.16K shares derived: average of 3 quarters · filed 2021-02-26 | 93.74M shares derived: average of 4 quarters · filed 2021-05-03 | |
| 2020-09-30 | 376.28K shares 10-K · filed 2021-02-26 | 376.28M shares 10-Q · filed 2020-11-05 | 375.90K shares derived: average of 2 quarters · filed 2021-02-26 | 375.22M shares 10-Q · filed 2020-11-05 | 93.74M shares derived: average of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | 375.52K shares 10-K · filed 2021-02-26 | 375.52M shares 10-Q · filed 2020-08-07 | 374.68M shares 10-Q · filed 2020-08-07 | 124.86M shares derived: average of 3 quarters · filed 2021-05-03 | 93.74M shares derived: average of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | 373.83M shares 10-Q · filed 2021-05-03 | 187.10M shares derived: average of 2 quarters · filed 2021-05-03 | 124.86M shares derived: average of 3 quarters · filed 2021-05-03 | 93.74M shares derived: average of 4 quarters · filed 2021-05-03 | |
| 2019-12-31 | 372.45K shares 10-K · filed 2021-02-26 | 372.45M shares 10-K · filed 2020-02-27 | 372.35K shares derived: average of 2 quarters · filed 2021-02-26 | 374.04K shares derived: average of 3 quarters · filed 2021-02-26 | 372.99K shares derived: average of 4 quarters · filed 2021-02-26 |
| 2019-09-30 | 372.25K shares 10-K · filed 2021-02-26 | 372.25M shares 10-Q · filed 2019-11-06 | 374.84K shares derived: average of 2 quarters · filed 2021-02-26 | 376.99M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 377.44K shares 10-K · filed 2021-02-26 | 377.44M shares 10-Q · filed 2019-08-07 | 376.67M shares 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | 369.82K shares 10-K · filed 2021-02-26 | 369.82M shares 10-K · filed 2020-02-27 | |||
| 2018-09-30 | 341.30M shares 10-Q · filed 2019-11-06 | 340.88M shares derived: average of 2 quarters · filed 2019-11-06 | 340.68M shares 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | 340.46M shares 10-Q · filed 2019-08-07 | 340.36M shares 10-Q · filed 2019-08-07 |